Skip to main content
. 2017 Aug 3;7(4):604–608. doi: 10.3892/mco.2017.1359

Table III.

Treatment-related adverse events (n=9).

Grade, n

Events 1 2 3 4 All-grade
Leukocytopenia 0 3 3 2 8
Neutropenia 0 3 2 3 8
Thrombocytopenia 1 2 0 0 3
Anemia 1 0 1 0 2
Febrile neutropenia 3 0 3
Appetite loss 4 0 1 0 5
Constipation 4 0 0 0 4
Vomiting 1 0 0 0 1
Fatigue 0 1 4 0 5
Rash 1 0 0 0 1
Peripheral neurotoxicity 0 1 0 0 1
Bleeding 0 0 0 0 0